| The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. | None |
| Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. | None |
| A novel oncoprotein Pirh2: rising from the shadow of MDM2. | None |
| Human oncoprotein mdm2 interacts with the tata-binding protein in-vitro and in-vivo. | None |
| The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression. | None |
| Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA. | None |
| Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1. | None |
| Overexpression of SKI oncoprotein leads to p53 degradation through regulation of MDM2 protein sumoylation. | None |
| HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. | None |
| Transcription factor NFAT1 activates the mdm2 oncogene independent of p53. | None |
| Transcription factor NFAT1 activates the mdm2 oncogene independent of p53. | None |
| Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. | None |
| FEZF2 acted as a histone deacetylase-associated repressor downregulating multiple oncogenes including EZH2 and MDM2, through direct binding to their promoters. | None |
| The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing. | None |
| Novel perspective: exercise training stimulus triggers the expression of the oncoprotein human double minute-2 in human skeletal muscle. | None |
| The regulation of MDM2 oncogene and its impact on human cancers. | None |
| Data show that NEDD4-1 E3 ligase as a novel component of the tumor suppressor protein p53/proto-oncogene proteins c-mdm2 regulatory feedback loop that controls p53 activity during stress responses. | None |
| Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. | None |
| Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours. | None |
| results reveal a novel p53- and Mdm2-independent oncogenic function of Mdmx that provides new insight into the many cancers that overexpress Mdmx. | None |